Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,569.68
(
0.08%
)
US TECH 100
29,453.60
(
0.10%
)
Dow Jones
50,876.58
(
0.41%
)
Brent Oil
91.18
(
-1.09%
)
Bitcoin
73,078.30
(
-0.63%
)
News Focus
News Focus
Post# of 257654
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

dav1234

Send PM Follow Ignore
Followers 97
Posts 92809
Boards Moderated 4
Alias Born 10/29/2007

dav1234

Re: None

Tuesday, 02/25/2014 5:02:34 PM

Tuesday, February 25, 2014 5:02:34 PM

Post# of 257654
Anika resumes trading, shares +14.7% AH
Anika (ANIK) has made new 52-week highs AH following news the FDA has approved its Monovisc osteoarthritis drug.The drug will be marketed in the U.S. by orthopedic sports medicine firm Mitek Sports Medicine. Anika will receive a $5M milestone payment once sales commence, and potentially additional milestone payments down the road.

http://m.seekingalpha.com/news/1590553-anikas-monovisc-approved-by-fda
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today